Envision Healthcare Corporation (NYSE:EVHC) had its target price reduced by Oppenheimer Holdings, Inc. from $77.00 to $40.00 in a note issued to investors on Thursday. The firm currently has an “outperform” rating on the stock. Oppenheimer Holdings, Inc.’s price target would suggest a potential upside of 47.93% from the stock’s current price.
A number of other research analysts have also recently issued reports on EVHC. KeyCorp decreased their price objective on shares of Envision Healthcare Corporation from $67.00 to $37.00 and set an “overweight” rating on the stock in a research note on Thursday. Zacks Investment Research raised shares of Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. Mizuho decreased their price objective on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 9th. Citigroup Inc. cut shares of Envision Healthcare Corporation from a “buy” rating to a “neutral” rating and set a $31.00 price objective on the stock. in a research note on Thursday. Finally, Canaccord Genuity reissued a “buy” rating and issued a $32.00 price objective (down from $68.00) on shares of Envision Healthcare Corporation in a research note on Thursday. Two analysts have rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $49.21.
Shares of Envision Healthcare Corporation (NYSE EVHC) traded down $0.21 during trading hours on Thursday, reaching $27.04. 4,795,013 shares of the company were exchanged, compared to its average volume of 5,488,916. The company has a market capitalization of $3,267.14, a PE ratio of 8.35, a price-to-earnings-growth ratio of 0.57 and a beta of 0.69. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 2.82. Envision Healthcare Corporation has a fifty-two week low of $26.56 and a fifty-two week high of $74.75.
Envision Healthcare Corporation (NYSE:EVHC) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $2.03 billion. Envision Healthcare Corporation had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business’s revenue was up 142.0% compared to the same quarter last year. During the same period last year, the business earned $1.13 earnings per share. sell-side analysts predict that Envision Healthcare Corporation will post 3.12 EPS for the current fiscal year.
Envision Healthcare Corporation announced that its Board of Directors has authorized a stock repurchase program on Monday, September 18th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 4.5% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.
ILLEGAL ACTIVITY WARNING: “Envision Healthcare Corporation (EVHC) PT Lowered to $40.00” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at https://www.com-unik.info/2017/11/05/envision-healthcare-corporation-evhc-pt-lowered-to-40-00.html.
Several institutional investors have recently modified their holdings of EVHC. Commonwealth Bank of Australia grew its stake in shares of Envision Healthcare Corporation by 24.3% in the second quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after purchasing an additional 410 shares during the last quarter. LMR Partners LLP bought a new stake in shares of Envision Healthcare Corporation in the second quarter worth $205,000. Palisade Capital Management LLC NJ bought a new stake in shares of Envision Healthcare Corporation in the third quarter worth $229,000. Cutter & CO Brokerage Inc. grew its stake in shares of Envision Healthcare Corporation by 11.1% in the second quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock worth $230,000 after purchasing an additional 367 shares during the last quarter. Finally, HighTower Advisors LLC grew its stake in shares of Envision Healthcare Corporation by 5.6% in the first quarter. HighTower Advisors LLC now owns 4,541 shares of the company’s stock worth $274,000 after purchasing an additional 240 shares during the last quarter.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
What are top analysts saying about Envision Healthcare Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Corporation and related companies.